-
公开(公告)号:US20240246899A1
公开(公告)日:2024-07-25
申请号:US18428938
申请日:2024-01-31
申请人: Celgene Corporation
发明人: John F. Traverse , Michael J. Zacuto , Weihong Zhang , Kirsten Faye Johnson , Maryll E. Geherty , Christopher Marton
IPC分类号: C07C231/18 , C07C67/313 , C07C231/02 , C07C231/12 , C07C237/06 , C07C237/12 , C07C273/18 , C07C275/24 , C07C275/70 , C07D209/46
CPC分类号: C07C231/18 , C07C67/313 , C07C231/02 , C07C231/12 , C07C237/06 , C07C237/12 , C07C273/1809 , C07C275/24 , C07C275/70 , C07D209/46
摘要: Provided are processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate, or a salt, solvate, hydrate, enantiomer, mixture of enantiomers, or isotopologue thereof. Also provided are solid forms of various intermediates and products obtained from the processes.
-
2.
公开(公告)号:US11998901B2
公开(公告)日:2024-06-04
申请号:US17676078
申请日:2022-02-18
发明人: Sukbok Chang , Seung Youn Hong , Yoon Su Park , Yeongyu Hwang , Yeong Bum Kim
IPC分类号: C07D207/267 , B01J31/22 , C07D209/34 , C07D209/46 , C07D209/52 , C07D209/54 , C07D209/56 , C07D209/70 , C07D403/04 , C07D405/04 , C07D409/04 , C07F15/06 , C07F17/02 , C07J43/00
CPC分类号: B01J31/2295 , C07D207/267 , C07D209/46 , C07D209/52 , C07D209/54 , C07D209/56 , C07D209/70 , C07D403/04 , C07D405/04 , C07D409/04 , C07F17/02 , C07J43/003 , B01J2231/60
摘要: The present invention relates to a novel metal complex, a method for producing same, and a method for producing a gamma-lactam compound using same, and the metal complex according to the present invention is used as a catalyst for producing a gamma-lactam compound and can efficiently produce a gamma-lactam compound with an excellent yield and excellent selectivity.
-
3.
公开(公告)号:US20230348456A1
公开(公告)日:2023-11-02
申请号:US18140302
申请日:2023-04-27
发明人: Janek SZYCHOWSKI , Bingcan LIU , Evelyne DIETRICH , Alexander PERRYMAN , Sheldon N. CRANE , Vouy Linh TRUONG , Abbas ABDOLI , Alexanne BOUCHARD
IPC分类号: C07D417/14 , C07D401/14 , C07D405/14 , C07D413/14 , C07D491/107 , C07D209/46 , C07D493/08 , C07D411/14
CPC分类号: C07D417/14 , C07D401/14 , C07D405/14 , C07D413/14 , C07D491/107 , C07D209/46 , C07D493/08 , C07D411/14
摘要: Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
-
公开(公告)号:US11731953B2
公开(公告)日:2023-08-22
申请号:US17354203
申请日:2021-06-22
发明人: Binh Vu , Romyr Dominique , Hongju Li , Bruce Fahr , Yi Chen
IPC分类号: C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/14 , C07D471/04 , C07D209/46 , C07D209/94 , C07D209/34
CPC分类号: C07D401/04 , C07D209/34 , C07D209/46 , C07D209/94 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04
摘要: Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods that restore DNA binding affinity of p53 mutants. The compounds of the present disclosure can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.
-
公开(公告)号:US11701373B2
公开(公告)日:2023-07-18
申请号:US17307138
申请日:2021-05-04
发明人: Alaric J. Dyckman , T. G. Murali Dhar , Hai-Yun Xiao , John L. Gilmore , Michael G. Yang , Zili Xiao , David Marcoux
IPC分类号: A61K31/695 , C07F7/08 , A61K31/135 , C07D215/14 , C07D241/04 , C07C323/29 , C07C251/38 , C07C251/42 , C07C251/44 , C07D209/46 , C07D213/38 , C07C275/26 , C07C217/74 , C07C323/25 , C07C235/46 , C07F9/54 , C07F9/572 , C07F9/09 , C07C215/42 , C07C217/52 , C07C217/58 , C07C219/24 , C07C233/41 , C07C233/65 , C07C251/50 , C07C251/52 , C07C251/54 , C07C271/34 , C07C317/28 , C07C317/32 , C07C321/16 , C07C321/22 , C07C321/28 , C07D213/32 , C07D213/69 , C07D213/70 , C07D215/12 , C07D217/24 , C07D231/12 , C07D231/20 , C07D239/26 , C07D241/12 , C07D277/24 , C07D305/08 , C07D309/06 , C07D309/12 , C07D311/58 , C07D311/76 , C07D319/20 , C07D333/16 , C07F9/117 , C07F9/62 , C07F9/6503 , C07F9/6509 , C07F9/655 , C07F9/6553 , A61K31/137 , A61K31/15 , A61K31/165 , A61K31/166 , A61K31/17 , A61K31/222 , A61K31/24 , A61K31/27 , A61K31/337 , A61K31/351 , A61K31/352 , A61K31/381 , A61K31/415 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/47 , A61K31/4965 , A61K31/505 , A61K31/661
CPC分类号: A61K31/695 , A61K31/135 , A61K31/137 , A61K31/15 , A61K31/165 , A61K31/166 , A61K31/17 , A61K31/222 , A61K31/24 , A61K31/27 , A61K31/337 , A61K31/351 , A61K31/352 , A61K31/381 , A61K31/415 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/47 , A61K31/4965 , A61K31/505 , A61K31/661 , C07C215/42 , C07C217/52 , C07C217/58 , C07C217/74 , C07C219/24 , C07C233/41 , C07C233/65 , C07C235/46 , C07C251/38 , C07C251/42 , C07C251/44 , C07C251/50 , C07C251/52 , C07C251/54 , C07C271/34 , C07C275/26 , C07C317/28 , C07C317/32 , C07C321/16 , C07C321/22 , C07C321/28 , C07C323/25 , C07C323/29 , C07D209/46 , C07D213/32 , C07D213/38 , C07D213/69 , C07D213/70 , C07D215/12 , C07D215/14 , C07D217/24 , C07D231/12 , C07D231/20 , C07D239/26 , C07D241/04 , C07D241/12 , C07D277/24 , C07D305/08 , C07D309/06 , C07D309/12 , C07D311/58 , C07D311/76 , C07D319/20 , C07D333/16 , C07F7/08 , C07F7/081 , C07F9/091 , C07F9/117 , C07F9/5442 , C07F9/5728 , C07F9/62 , C07F9/65031 , C07F9/65522 , C07F9/650952 , C07F9/655345 , C07B2200/05 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2602/10 , C07C2603/74
摘要: Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V):
and/or a salt thereof, wherein R1 is —OH or —OP(O)(OH)2, and X1, X2, X3, R2, R2a, Ra, Rb, and Rc are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.-
公开(公告)号:US20180141934A1
公开(公告)日:2018-05-24
申请号:US15794800
申请日:2017-10-26
申请人: CHEMOCENTRYX, INC.
发明人: Xi CHEN , Dean R. DRAGOLI , Junfa FAN , Jaroslaw KALISIAK , Antoni KRASINSKI , Manmohan Reddy LELETI , Venkat MALI , Jeffrey McMAHON , Rajinder SINGH , Hiroko TANAKA , Ju YANG , Chao YU , Penglie ZHANG
IPC分类号: C07D405/14 , A61K31/506 , C07D405/12 , C07D307/52 , C07D209/46 , A61K45/06 , A61K31/341 , A61K31/4725 , A61K31/454 , A61K31/4439 , A61K31/4155 , A61K31/4035
CPC分类号: C07D405/14 , A61K31/341 , A61K31/4035 , A61K31/4155 , A61K31/4439 , A61K31/454 , A61K31/4725 , A61K31/506 , A61K45/06 , A61P35/00 , C07D209/46 , C07D307/52 , C07D405/12
摘要: Compounds are provided as chemokine inhibitors having the structure:
-
公开(公告)号:US09834545B2
公开(公告)日:2017-12-05
申请号:US15353889
申请日:2016-11-17
申请人: CHEMOCENTRYX, INC.
发明人: Xi Chen , Dean R. Dragoli , Junfa Fan , Jaroslaw Kalisiak , Antoni Krasinski , Manmohan Reddy Leleti , Venkat Mali , Jeffrey McMahon , Rajinder Singh , Hiroko Tanaka , Ju Yang , Chao Yu , Penglie Zhang
IPC分类号: C07D405/14 , A61K31/506 , A61K31/4155 , A61K31/4439 , A61K31/454 , A61K31/341 , A61K31/4035 , A61K45/06 , C07D209/46 , C07D307/52 , C07D405/12 , A61K31/4725
CPC分类号: C07D405/14 , A61K31/341 , A61K31/4035 , A61K31/4155 , A61K31/4439 , A61K31/454 , A61K31/4725 , A61K31/506 , A61K45/06 , C07D209/46 , C07D307/52 , C07D405/12
摘要: Compounds are provided as chemokine inhibitors having the structure:
-
公开(公告)号:US09822070B2
公开(公告)日:2017-11-21
申请号:US15111507
申请日:2015-01-14
IPC分类号: C07D209/46 , C08G64/12 , B01J27/125
CPC分类号: C07D209/46 , B01J27/125 , C08G64/12
摘要: A method for the manufacture of a 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidine composition comprises: reacting a phthalimide with a phenol in the presence of a catalyst and optionally a solvent at an elevated temperature to form the 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidine composition.
-
公开(公告)号:US09783488B2
公开(公告)日:2017-10-10
申请号:US14776280
申请日:2014-03-10
发明人: Celia Dominguez , Ignacio Muñoz-Sanjuán , Michel Maillard , Gilles Raphy , Alan F. Haughan , Christopher A. Luckhurst , Rebecca E. Jarvis , Roland W. Bürli , Perla Breccia , Grant Wishart , Samantha J. Hughes , Daniel R. Allen , Stephen D. Penrose
IPC分类号: A61K31/133 , C07C233/60 , C07D263/56 , C07D215/14 , C07D231/12 , C07D231/56 , C07D333/54 , C07D235/08 , C07D239/26 , C07D471/04 , C07D265/36 , C07D277/64 , C07D295/073 , C07D213/54 , C07D213/56 , C07D307/79 , C07C259/08 , C07D209/46 , C07D213/58 , C07D215/06 , C07D235/06 , C07D263/57 , C07D265/30 , C07D277/66 , C07D307/81 , C07D311/96 , C07D401/12 , C07D413/06
CPC分类号: C07C233/60 , C07C259/08 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07D209/46 , C07D213/54 , C07D213/56 , C07D213/58 , C07D215/06 , C07D215/14 , C07D231/12 , C07D231/56 , C07D235/06 , C07D235/08 , C07D239/26 , C07D263/56 , C07D263/57 , C07D265/30 , C07D265/36 , C07D277/64 , C07D277/66 , C07D295/073 , C07D307/79 , C07D307/81 , C07D311/96 , C07D333/54 , C07D401/12 , C07D413/06 , C07D471/04
摘要: Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.
-
公开(公告)号:US09775827B2
公开(公告)日:2017-10-03
申请号:US15488002
申请日:2017-04-14
发明人: Masami Yamada , Shinkichi Suzuki , Takahiro Sugimoto , Minoru Nakamura , Hiroki Sakamoto , Makoto Kamata
IPC分类号: C07D209/46 , C07D403/10 , C07D405/14 , C07D403/04 , C07D401/10 , C07D401/14 , A61K31/4035 , A61K31/445 , A61K31/55 , A61K31/325 , A61K31/4155 , A61K31/4439
CPC分类号: C07D405/14 , A61K31/045 , A61K31/13 , A61K31/325 , A61K31/4035 , A61K31/4155 , A61K31/4406 , A61K31/4439 , A61K31/445 , A61K31/55 , C07D209/46 , C07D401/06 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/10 , C07D405/04 , C07D471/04
摘要: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like.The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
-
-
-
-
-
-
-
-
-